Incannex Net Income Per Share from 2010 to 2026

IXHL Stock  USD 0.28  0.01  3.45%   
Incannex Healthcare Net Loss yearly trend continues to be quite stable with very little volatility. Net Loss may rise above -1.16 this year. From the period between 2010 and 2026, Incannex Healthcare, Net Loss regression line of its data series had sample variance of  0.23 and sample variance of  0.23. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(1.22)
Current Value
(1.16)
Quarterly Volatility
0.48184098
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Incannex Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incannex Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 486.7 K, Interest Expense of 365.9 K or Gross Profit of 86.7 K, as well as many indicators such as Price To Sales Ratio of 94.41, Dividend Yield of 0.0 or PTB Ratio of 0.67. Incannex financial statements analysis is a perfect complement when working with Incannex Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Incannex Stock
Check out the analysis of Incannex Healthcare Correlation against competitors.
Historical Net Income Per Share data for Incannex Healthcare serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Incannex Healthcare Ltd represents a compelling investment opportunity.

Latest Incannex Healthcare's Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of Incannex Healthcare Ltd over the last few years. It is Incannex Healthcare's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incannex Healthcare's overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

Incannex Net Income Per Share Regression Statistics

Arithmetic Mean(0.42)
Coefficient Of Variation(114.91)
Mean Deviation0.39
Median(0.17)
Standard Deviation0.48
Sample Variance0.23
Range1.3438
R-Value(0.36)
Mean Square Error0.22
R-Squared0.13
Significance0.16
Slope(0.03)
Total Sum of Squares3.71

Incannex Net Income Per Share History

2026 -1.16
2025 -1.22
2024 -1.36
2023 -0.17
2022 -0.32
2021 -0.0344
2020 -0.0349

About Incannex Healthcare Financial Statements

Incannex Healthcare investors utilize fundamental indicators, such as Net Income Per Share, to predict how Incannex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss(1.22)(1.16)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Incannex Healthcare is a strong investment it is important to analyze Incannex Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Incannex Healthcare's future performance. For an informed investment choice regarding Incannex Stock, refer to the following important reports:
Check out the analysis of Incannex Healthcare Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. Market participants price Incannex higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Incannex Healthcare assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.09)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.30)
Return On Equity
(1.15)
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Incannex Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.